We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.42%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$40.8B
AUM Growth
-$2.75B
(-6.3%)
Cap. Flow
-$4B
Cap. Flow
% of AUM
-9.79%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
1,449
New
354
Increased
347
Reduced
344
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$612M |
| 2 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$454M |
| 3 |
BP
BP
|
+$442M |
| 4 |
TSMC
TSM
|
+$416M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$398M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$959M |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
UnitedHealth
UNH
|
+$534M |
| 4 |
Applied Materials
AMAT
|
+$508M |
| 5 |
Walt Disney
DIS
|
+$409M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.15% |
| 2 | Healthcare | 18.68% |
| 3 | Financials | 14.67% |
| 4 | Consumer Discretionary | 11.82% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
GoDaddy
GDDY
$11.5B
| $642K | ﹤0.01% |
+9,100
| New | +$619K |
|
|
CO
877
DELISTED
Global Cord Blood Corporation
CO
| $623K | ﹤0.01% |
65,634
-418,557
| -86% | -$4.01M |
|
878
Cencora
COR
$61.2B
| $622K | ﹤0.01% |
7,300
-122,300
| -94% | -$10.7M |
|
879
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $620K | ﹤0.01% |
14,700
+9,500
| +183% | +$429K |
|
|
CEL
880
DELISTED
Cellcom Israel, Ltd.
CEL
| $615K | ﹤0.01% |
+108,240
| New | +$735K |
|
|
FL
881
DELISTED
Foot Locker
FL
| $611K | ﹤0.01% |
+11,600
| New | +$561K |
|
|
ATTU
882
DELISTED
Attunity Ltd
ATTU
| $611K | ﹤0.01% |
+52,662
| New | +$526K |
|
883
SandRidge Energy
SD
$503M
| $607K | ﹤0.01% |
+34,200
| New | +$512K |
|
884
ExxonMobil
XOM
$634B
| $606K | ﹤0.01% |
7,322
-326,278
| -98% | -$26M |
|
885
Vericel Corp
VCEL
$2.31B
| $604K | ﹤0.01% |
+62,239
| New | +$775K |
|
886
BlueLinx
BXC
$706M
| $600K | ﹤0.01% |
+16,000
| New | +$625K |
|
887
Myriad Genetics
MYGN
$312M
| $598K | ﹤0.01% |
16,000
-12,248
| -43% | -$414K |
|
888
Village Super Market
VLGEA
$639M
| $598K | ﹤0.01% |
+20,288
| New | +$571K |
|
889
Kenon Holdings
KEN
$3.45B
| $597K | ﹤0.01% |
+39,342
| New | +$618K |
|
890
Tilly's
TLYS
$128M
| $597K | ﹤0.01% |
+39,410
| New | +$501K |
|
891
Evolution Petroleum
EPM
$131M
| $588K | ﹤0.01% |
+59,706
| New | +$550K |
|
892
Lesaka Technologies
LSAK
$420M
| $588K | ﹤0.01% |
64,732
+47,732
| +281% | +$441K |
|
|
HMSY
893
DELISTED
HMS Holdings Corp.
HMSY
| $584K | ﹤0.01% |
+27,031
| New | +$546K |
|
894
Ooma
OOMA
$604M
| $577K | ﹤0.01% |
40,776
+2,418
| +6% | +$28.3K |
|
895
Banco Santander
SAN
$210B
| $577K | ﹤0.01% |
+112,696
| New | +$659K |
|
896
Labcorp
LH
$25.9B
| $574K | ﹤0.01% |
3,725
-238,620
| -98% | -$36M |
|
897
Domino's
DPZ
$11.6B
| $564K | ﹤0.01% |
+2,000
| New | +$507K |
|
898
Bassett Furniture
BSET
$176M
| $562K | ﹤0.01% |
20,400
+9,400
| +85% | +$267K |
|
899
Protagonist Therapeutics
PTGX
$9.44B
| $560K | ﹤0.01% |
+83,341
| New | +$640K |
|
900
V2X
VVX
$2.65B
| $558K | ﹤0.01% |
18,092
-89,034
| -83% | -$3.01M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Arrowstreet Capital held 1,449 positions worth $40.8B, down 6.3% from $43.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Arrowstreet Capital withdrew a net $4B in Q2 2018, closing 396 positions and reducing 344 holdings. Its most notable exit was Applied Materials, an estimated $508M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Arrowstreet Capital opened a new position in Stellantis worth $85.1M.
- Arrowstreet Capital's largest Q2 2018 buy was Stellantis: 4,458,651 shares worth $85.1M.
- Arrowstreet Capital added most to Microsoft in Q2 2018, an estimated $612M increase.
- Arrowstreet Capital's biggest Q2 2018 reduction was Boeing, cutting an estimated $959M.
- Arrowstreet Capital fully exited Applied Materials in Q2 2018, selling an estimated $508M.
- Arrowstreet Capital's ten largest holdings make up 20% of its $40.8B portfolio in Q2 2018.
- Arrowstreet Capital opened 354 new positions and closed 396 in Q2 2018.
- Arrowstreet Capital's portfolio value fell 6.3% quarter-over-quarter to $40.8B.
Based on Arrowstreet Capital's 13F filing for Q2 2018, filed 14 Aug 2018.